| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/26/2011 | EP2278328A2 Method for characterising effect yarn |
| 01/26/2011 | EP2278327A1 System and Method for Screening Liquid Compositions |
| 01/26/2011 | EP2278326A1 Method for measuring the cryoscopic point of milk and its by-products with thermistor device |
| 01/26/2011 | EP2278319A1 Device for evaluating degree of degradation of lubricating oil |
| 01/26/2011 | EP2278318A1 Method, device and apparatus for measuring creatinine concentration, and method, device and apparatus for measuring salt content in urine using same |
| 01/26/2011 | EP2278317A1 Field effect transistor device for ultra-fast nucleic acid sequencing |
| 01/26/2011 | EP2278315A1 Analyte test strip having predetermined calibration characteristics |
| 01/26/2011 | EP2278313A1 Electrodes, methods, apparatuses comprising micro-electrode arrays |
| 01/26/2011 | EP2278311A2 Destructible Surfactants And Uses Thereof |
| 01/26/2011 | EP2278309A1 A Sensor |
| 01/26/2011 | EP2278300A1 Device comprising a polymer layer and a reflecting layer |
| 01/26/2011 | EP2278030A2 Methods for the survey and genetic analysis of populations |
| 01/26/2011 | EP2278029A2 Methods for the survey and genetic analysis of populations |
| 01/26/2011 | EP2278028A1 Method for diagnosing non-small cell lung cancers |
| 01/26/2011 | EP2278027A2 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores |
| 01/26/2011 | EP2278025A1 Method for evaluation of degree of malignancy of tumor cell |
| 01/26/2011 | EP2278024A1 Epitope cluster from NY-ESO-1 for the induction of anti-tumor immunogenicity |
| 01/26/2011 | EP2278023A1 Epitope cluster from Melan-A/MART-1 for the induction of anti-tumor immunogenicity |
| 01/26/2011 | EP2278013A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/26/2011 | EP2278011A2 Neisseria meningitidis antigens |
| 01/26/2011 | EP2278010A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278009A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278008A2 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278007A1 Conserved neisserial antigens |
| 01/26/2011 | EP2278006A2 Neisserial antigens |
| 01/26/2011 | EP2278005A2 Fuctional and hyperfunctional sirna |
| 01/26/2011 | EP2278003A2 Method for controlling the activity of immunologically functional molecule |
| 01/26/2011 | EP2277991A1 Method and quantification assay for determining c-kit/SCF/pAKT status |
| 01/26/2011 | EP2277917A2 B7-H3L cell surface target and a family of antibodies recognizing that target |
| 01/26/2011 | EP2277908A2 IL-17A/F heterologous polypeptides, antibodies and therapeutic uses thereof |
| 01/26/2011 | EP2277907A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277906A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277905A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277904A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277903A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277902A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277901A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277897A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/26/2011 | EP2277893A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/26/2011 | EP2277892A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/26/2011 | EP2277891A1 CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS POLYMERASE PAc-PB1n COMPLEX AND USES THEREOF |
| 01/26/2011 | EP2277873A1 Intermediate compound for the preparation of halichondrin analogs |
| 01/26/2011 | EP2277615A2 Methods and apparatuses for analyzing biological samples by mass spectrometry |
| 01/26/2011 | EP2277552A1 Mnk kinase proteins and diabetes |
| 01/26/2011 | EP2277542A1 Modified antibodies to prostrate-specific membrane antigen and uses thereof |
| 01/26/2011 | EP2277534A1 Immunogenic and therapeutic compositions for streptococcus suis |
| 01/26/2011 | EP2277533A2 Methods for vaccinating against malaria |
| 01/26/2011 | EP2277532A1 Novel composition and methods for the treatment of immune related diseases |
| 01/26/2011 | EP2277531A1 Treatment of cns damage |
| 01/26/2011 | EP2277530A1 Glucagon-like peptide-2 and its therapeutic use |
| 01/26/2011 | EP2277522A2 Methods for increasing or decreasing bone density and identifying molecules |
| 01/26/2011 | EP2277052A2 Device for detecting at least one element contained in a blood solution |
| 01/26/2011 | EP2277051A1 Method for detecting the existence of renal calculi and/or inflammation of the excretory urinary tracts |
| 01/26/2011 | EP2277050A1 Analysis of amino acid copolymer compositions |
| 01/26/2011 | EP2277049A2 Autoantibodies in the detection and treatment of cancer |
| 01/26/2011 | EP2277048A1 A method for sensing a chemical |
| 01/26/2011 | EP2277047A2 Time-resolved fluorescence energy transfer (tr-fret) assay for detecting exposure to an infectious organism |
| 01/26/2011 | EP2277046A2 Non-inflammatory gluten peptide analogues as biomarkers for celiac sprue |
| 01/26/2011 | EP2277045A2 Process for fabricating nanowire arrays |
| 01/26/2011 | EP2277044A1 Analysis of antibody drug conjugates by bead-based affinity capture and mass spectrometry |
| 01/26/2011 | EP2277043A2 Screening for modulators of cyp2b15 and/or gpd1 for the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 01/26/2011 | EP2277042A1 The alcohol thermal dehydratation chamber, apparatus and method for determination of isotopic composition of non-exchangeable hydrogen and deuterium atoms in ethanol samples |
| 01/26/2011 | EP2277041A1 Device and method for detecting trace gases |
| 01/26/2011 | EP2277040A1 Acetaminophen-protein adduct assay device and method |
| 01/26/2011 | EP2277035A1 Evaluation and control unit for a broadband lambda probe |
| 01/26/2011 | EP2277032A1 A molecule detecting system |
| 01/26/2011 | EP2276854A1 Cidea modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 01/26/2011 | EP2276571A1 A sensor array and a method of manufacturing the same |
| 01/26/2011 | EP2276570A1 Microfluidic chip devices and their use |
| 01/26/2011 | EP2276549A1 Method and apparatus for separating particles in a fluid |
| 01/26/2011 | EP2094845B1 Artificial binding proteins based on a modified alpha helical region of ubiquitin |
| 01/26/2011 | EP2079827B1 Multi-well micropatterning by ablation |
| 01/26/2011 | EP2053914B1 Method of identifying of cows, sires and bull dams producing milk with modified coagulation properties |
| 01/26/2011 | EP2024740B1 Method for detection and classification of flaws in components by means of ultrasound |
| 01/26/2011 | EP1878801B1 Protein cleavage method and use thereof |
| 01/26/2011 | EP1851310B1 Crystal structure of tak1-tab1 |
| 01/26/2011 | EP1842066B1 Biologically active silver-coated proteins |
| 01/26/2011 | EP1817337B1 Therapeutic peptides comprising sequences derived from cdr2 or cdr3 of trem-1 and uses thereof to inhibit sepsis |
| 01/26/2011 | EP1797431B1 Detection of elevated levels of her-2/neu protein on circulating cancer cells and treatment |
| 01/26/2011 | EP1687628B1 Fluid sample analysis device with sealable sample storage reservoir |
| 01/26/2011 | EP1636583B1 Human g protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders |
| 01/26/2011 | EP1581649B1 Binding agents which inhibit myostatin |
| 01/26/2011 | EP1578778B1 Ghrelin analogs |
| 01/26/2011 | EP1556489B1 Pharmaceutical composition for preparing a medicine for treating and/or preventing a pathology related to an obsessive behaviour or obesity |
| 01/26/2011 | EP1539956B1 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 01/26/2011 | EP1404365B1 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 01/26/2011 | EP1368637B1 Mid infra red analysis |
| 01/26/2011 | EP1356264B1 Apparatus for non-destructively testing material |
| 01/26/2011 | EP1349954B1 Materials and methods for detection of nucleic acids |
| 01/26/2011 | EP1261621B1 Phosphorylation assays |
| 01/26/2011 | EP1190260B1 Detection of von-willebrand factor (vwf) activity |
| 01/26/2011 | EP1179004B1 Potassium channel kcnq5 |
| 01/26/2011 | EP0951552B1 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 01/26/2011 | EP0946725B1 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily |
| 01/26/2011 | CN201725233U Flow type multigap resistive plate chambers (MRPC) constant temperature testing cassete |
| 01/26/2011 | CN201724941U Immune colloidal gold reagent plate for detecting tripolycyanamide |
| 01/26/2011 | CN201724940U Immunochromatographic test strip with bar code layer |
| 01/26/2011 | CN201724939U Westernblot reaction box |
| 01/26/2011 | CN201724938U Chemiluminescence immunoassay system for RFID (Radio Frequency Ddentification Device) identification of kit |
| 01/26/2011 | CN201724937U Closely circulated perfusion system |